免疫组织化学检测在卵巢肿瘤病理诊断和鉴别诊断中的价值分析

The value of immunohistochemistry in pathological diagnosis and differential diagnosis of ovarian tumors

目的探究卵巢肿瘤采用免疫组织化学检测的病理诊断和鉴别诊断的临床价值。方法100例卵巢肿瘤患者,均实施免疫组织化学诊断配合超声诊断,分析患者病理诊断结果及鉴别诊断结果。结果100例卵巢肿瘤患者经免疫组织化学病理诊断原发性肿瘤91例(91.00%),转移性肿瘤9例(9.00%)。91例原发性肿瘤患者中,42例为表面上皮-间质性肿瘤,占比为42.00%;19例为生殖细胞肿瘤患者,占比为19.00%;18例为性索-间质肿瘤患者,占比为18.00%;12例为非特殊性软组织肿瘤,占比为12.00%。结论卵巢肿瘤患者采用免疫组织化学病理诊断,可有效鉴别疾病,医学价值高,可广泛用于临床,对患者具有重要意义。

Objective To investigate the clinical value of immunohistochemistry in pathological diagnosis and differential diagnosis of ovarian tumors.Methods Immunohistochemical diagnosis combined with ultrasound diagnosis was performed in 100 patients with ovarian tumor,and pathological diagnosis and differential diagnosis results were analyzed.Results Among 100 patients with ovarian tumors,91 cases(91.00%)were diagnosed with primary tumors and 9 cases(9.00%)with metastatic tumors by immunohistochemical diagnosis.Among the 91 patients with primary tumors,42 cases were surface epithelial-stromal tumors,accounting for 42.00%;19 cases were germ cell tumor,accounting for 19.00%;18 cases were sex cord-stromal tumors,accounting for 18.00%;12 cases were non-specific soft tissue tumors,accounting for 12.00%.Conclusion The diagnosis of ovarian tumor by immunohistochemistry is of great medical value and can be widely used in clinic.It is of great significance to the patients.